IntrinsicIntrinsic

Other Events ·

Stockholders approve issuance of up to 1,236,668 shares upon exercise of warrants

BKYIBio Key International Inc

BIO-KEY International stockholders approved Proposal 4 at the reconvened Annual Meeting on October 30, 2026. The proposal sought approval under Nasdaq Listing Rule 5635(d) to issue up to 1,236,668 shares of common stock upon the exercise of warrants issued in an August 10, 2026 inducement transaction. Voting results were 129,795 for and 89,849 against. The company develops biometric authentication solutions.

More from Bio Key International Inc

Explore BKYI